Monday, February 17, 2014

8 Largest US Diagnostic Substances Company Stock Prices Down 53% Due to Financial Meltdown Spillover Effects, Then Up 248% Under Obama and the US Fed

I found 8 US Diagnostic Substances Companies classified in the Health Care Sector at Yahoo's superb Finance website with current Total Market Capitalizations of at least $100 mil and which also had their common stocks trading on each of the following three dates:

  • On December 31, 2007 during President Bush's second term
  • On March 6, 2009, very early in President Obama's first term, which was their lowest point due to the spillover effects resulting from the 2008 financial meltdown, and 
  • also on the most recent date February 14, 2014.

The historical common stock prices of these companies were obtained from the following two excellent internet resources....  Google Finance and MarketWatch Big Charts.

These 8 largest US Diagnostic Substances Companies had their average stock prices decline by a huge 53% from December 31, 2007 during President Bush's second Presidential term, to March 6, 2009, very early in President Obama's first term, which was the very lowest point for the overall stock market due to the spillover effects resulting from the disastrous 2008 Financial Meltdown.

But in the slightly less than five years since March 6, 2009, the average stock prices of these same 8 largest US Diagnostic Substances Companies have increased by a robust 248% through February 14, 2014, led by Tucson, AZ-based Accelerate Diagnostics.

7 of these 8 US Diagnostic Substances Companies experienced stock price increases since March 6, 2009.
 
Clearly, a majority of the investors in and employees of these 8 largest US Diagnostic Substances Companies must be pleased with the impact of actions taken by both the Obama Administration and the US Fed to successfully rescue the US economy from its extremely weakened state.

Also, all of these US Diagnostic Substances Companies are huge beneficiaries of the Affordable Care Act. 

Below here are the stock market prices of each of these 8 largest US Diagnostic Substances Companies on February 14, 2014, on March 6, 2009, and on  December 31, 2007:






Market Market






Price Price






% %






Change Change



Market Market Market 3-6-09 12-31-07



Price Price Price to to
Diagnostic Substances Company HQs
2-14-14 3-6-09 12-31-07 2-14-14 3-6-09








Accelerate Diagnostics Tucson AZ       13.93         1.41         4.63 888% -70%
Neogen Lansing MI       41.78         8.40       11.80 397% -29%
IDEXX Laboratories Westbrook ME      124.00       29.23       58.63 324% -50%
Quidel San Diego CA       27.99         9.55       19.47 193% -51%
Abaxis Union City CA       38.50       16.14       35.86 139% -55%
SurModics Eden Prairie MN       24.64       16.87       54.27 46% -69%
Meridian Bioscience Cincinnati OH       20.94       17.86       30.08 17% -41%
AMAG Pharmaceuticals Lexington MA       20.36       24.62       60.13 -17% -59%








Average % Change all 8




248% -53%